DK3440208T3 - Vektorer til kloning og ekspression af proteiner, metoder og anvendelser heraf - Google Patents
Vektorer til kloning og ekspression af proteiner, metoder og anvendelser heraf Download PDFInfo
- Publication number
- DK3440208T3 DK3440208T3 DK17722873.1T DK17722873T DK3440208T3 DK 3440208 T3 DK3440208 T3 DK 3440208T3 DK 17722873 T DK17722873 T DK 17722873T DK 3440208 T3 DK3440208 T3 DK 3440208T3
- Authority
- DK
- Denmark
- Prior art keywords
- cloning
- vectors
- proteins
- expression
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/005—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/80—Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/80—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
- C12N2810/85—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/20—Vector systems having a special element relevant for transcription transcription of more than one cistron
- C12N2830/205—Vector systems having a special element relevant for transcription transcription of more than one cistron bidirectional
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201641012164 | 2016-04-06 | ||
PCT/IB2017/051990 WO2017175176A1 (en) | 2016-04-06 | 2017-04-06 | Vectors for cloning and expression of proteins, methods and applications thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3440208T3 true DK3440208T3 (da) | 2020-12-07 |
Family
ID=58699192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK17722873.1T DK3440208T3 (da) | 2016-04-06 | 2017-04-06 | Vektorer til kloning og ekspression af proteiner, metoder og anvendelser heraf |
Country Status (9)
Country | Link |
---|---|
US (1) | US11549119B2 (da) |
EP (1) | EP3440208B1 (da) |
JP (1) | JP6987076B2 (da) |
KR (1) | KR102165777B1 (da) |
CA (1) | CA3018936C (da) |
DK (1) | DK3440208T3 (da) |
ES (1) | ES2837482T3 (da) |
PT (1) | PT3440208T (da) |
WO (1) | WO2017175176A1 (da) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3584258A1 (en) | 2018-06-19 | 2019-12-25 | IEO - Istituto Europeo di Oncologia Srl | Antibodies anti tumor associated antigens and method for obtaining them |
CN112646833A (zh) | 2020-11-05 | 2021-04-13 | 杭州阿诺生物医药科技有限公司 | 一种全人源抗体酵母展示技术的设计与构建 |
CN115109794A (zh) * | 2022-06-30 | 2022-09-27 | 武汉生之源生物科技股份有限公司 | 一种噬菌粒载体及其制备方法和应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
US5667988A (en) * | 1992-01-27 | 1997-09-16 | The Scripps Research Institute | Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
US6300065B1 (en) | 1996-05-31 | 2001-10-09 | Board Of Trustees Of The University Of Illinois | Yeast cell surface display of proteins and uses thereof |
NZ514569A (en) * | 1999-03-02 | 2004-02-27 | Invitrogen Corp | Compositions and methods for use in recombinational cloning of nucleic acids |
ES2549440T3 (es) * | 1999-05-18 | 2015-10-28 | Dyax Corp. | Bibliotecas de fragmentos de Fab y métodos para su uso |
DE60209009T2 (de) * | 2001-04-27 | 2006-10-05 | Alexion Pharmaceuticals, Inc., Cheshire | Phagemidvektoren |
GB0111015D0 (en) * | 2001-05-04 | 2001-06-27 | Norsk Hydro As | Genetic material |
US7244592B2 (en) * | 2002-03-07 | 2007-07-17 | Dyax Corp. | Ligand screening and discovery |
JP4748984B2 (ja) * | 2002-06-16 | 2011-08-17 | ダイアックス、コープ | 核酸ライブラリーメンバーの組換え |
US7795411B2 (en) * | 2006-10-05 | 2010-09-14 | Fred Hutchinson Cancer Research Center | Vectors for expressing in vivo biotinylated recombinant proteins |
US9556272B2 (en) * | 2009-11-11 | 2017-01-31 | The Trustees Of The University Of Pennsylvania | Anti-TEM1 antibodies and uses thereof |
US20130085072A1 (en) * | 2011-10-03 | 2013-04-04 | Los Alamos National Security, Llc | Recombinant renewable polyclonal antibodies |
JP2018511303A (ja) * | 2015-02-04 | 2018-04-26 | アブセレックス テクノロジーズ インコーポレイテッド | 抗サルモネラ抗体及びその使用 |
-
2017
- 2017-04-06 WO PCT/IB2017/051990 patent/WO2017175176A1/en active Application Filing
- 2017-04-06 CA CA3018936A patent/CA3018936C/en active Active
- 2017-04-06 JP JP2018553115A patent/JP6987076B2/ja active Active
- 2017-04-06 DK DK17722873.1T patent/DK3440208T3/da active
- 2017-04-06 PT PT177228731T patent/PT3440208T/pt unknown
- 2017-04-06 ES ES17722873T patent/ES2837482T3/es active Active
- 2017-04-06 US US16/090,783 patent/US11549119B2/en active Active
- 2017-04-06 KR KR1020187031366A patent/KR102165777B1/ko active IP Right Grant
- 2017-04-06 EP EP17722873.1A patent/EP3440208B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3440208A1 (en) | 2019-02-13 |
WO2017175176A1 (en) | 2017-10-12 |
US20190119691A1 (en) | 2019-04-25 |
CA3018936C (en) | 2021-10-19 |
CA3018936A1 (en) | 2017-10-12 |
ES2837482T3 (es) | 2021-06-30 |
JP2019510505A (ja) | 2019-04-18 |
PT3440208T (pt) | 2020-12-04 |
JP6987076B2 (ja) | 2021-12-22 |
US11549119B2 (en) | 2023-01-10 |
EP3440208B1 (en) | 2020-09-16 |
KR102165777B1 (ko) | 2020-10-14 |
KR20190015700A (ko) | 2019-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3356390T3 (da) | Fremgangsmåder og sammensætninger til virusvektorer, der undgår antistoffer | |
DK3294762T3 (da) | Ekspressionskonstruktioner og fremgangsmåder til genmanipulering af methylotrof gær | |
DK3356404T3 (da) | Anti-pd1-antistoffer og fremgangsmåder til anvendelse | |
DK3277717T3 (da) | En hidtil ukendt il33-form, muterede former af il33, antistoffer, assays og fremgangsmåder til anvendelse deraf | |
DK3185868T3 (da) | Hidtil ukendte ULK1-inhibitorer og fremgangsmåder til anvendelse af samme | |
DK3390430T3 (da) | Human immundefektvirus-antigener, vektorer, sammensætninger og fremgangsmåder til anvendelse deraf | |
DK3107938T3 (da) | Modificerede, antigenbindende polypeptidkonstrukter og anvendelser heraf | |
DK3198018T3 (da) | Vektorvarianter af adenoassocieret virus til højeffektiv genomredigering og fremgangsmåder dertil | |
DK3212778T3 (da) | Fremgangsmåder og sammensætninger til stabilisering af trans-splejsning af intein-modificerede proteaser | |
DK3280727T3 (da) | Enkeltarmede type i- og type ii-receptorfusionsproteiner og anvendelser deraf | |
DK3557998T3 (da) | Sammensætninger, kompositioner og anvendelsesmetoder | |
DK3559000T3 (da) | Benzimidazol-derivater, fremgangsmåder til fremstilling og anvendelser deraf | |
DK3250610T3 (da) | Fcrn-antistoffer og fremgangsmåder til anvendelse heraf | |
DK3565579T3 (da) | Pd1-41bbl-fusionsprotein og fremgangsmåder til anvendelse deraf | |
DK3402483T3 (da) | Fremgangsmåder og sammensætninger til aktivering af gamma-delta-T-celler | |
DK3201336T3 (da) | Fremgangsmåder til ekstrahering og oprensning af ikke-denaturerede proteiner | |
DK3096798T3 (da) | Plasmakallikreinbindende proteiner og anvendelser deraf til behandling af hereditært angioødem | |
DK3350201T3 (da) | Manipulerede fytaser og fremgangsmåder til anvendelse af samme | |
DK3519572T3 (da) | Forbindelser og fremgangsmåder til reduktion af tau-ekspression | |
DK3426777T3 (da) | Kombinationsvektorer og fremgangsmåder til behandling af cancer | |
DK3268024T3 (da) | Rekombinante glut1-adeno-associerede virusvektorkonstrukter og relaterede fremgangsmåder til genoprettelse af glut1-ekspression | |
DK3377618T3 (da) | Buffere til stabilisering af lentivirus-præparater | |
DK3498292T3 (da) | Uspa2-proteinkonstruktioner og anvendelser deraf | |
DK3368655T3 (da) | Forbedret proteinekspression og fremgangsmåder dertil | |
DK3565828T3 (da) | Sirp1 alpha-41bbl-fusionsprotein og fremgangsmåder til anvendelse deraf |